Adverse Events Management During Albendazole Mass Drug Administration: A Pilot Study Experiences from A District of Andhra Pradesh, India

Authors

  • Ciddhavaduta Deepa Latha Professor & Head of Department, Department of Pharmacology, Mamata Academy of Medical Sciences, Bachupally, Hyderabad Author
  • Vivekanandan Kalaiselvan Principal Scientific Officer, Indian Pharmacopoeia Commission, Government of India (Ministry of Health & Family Welfare) Author
  • Nadithe Laxman Reddy 3Assistant Professor, Department of Pharmacology, Mamtha Academy of Medical sciences, Bachupally, Hyderabad Author
  • Raja Vikram Prasad Professor, Department of Community Medicine, Mamata Academy of Medical Sciences, Hyderabad Author

DOI:

https://doi.org/10.47363/JCBR/2021(3)124

Keywords:

Albendazole, National Deworming Programme, Adverse Events.

Abstract

Focussed Surveillance of Albendazole Mass Drug Administration T his pilot study describes the field experiences of integrated approach of regional Adverse Drug Reactions monitoring centre (AMC) under Pharmacovigilance Programme of India (PvPI) and National de worming program in Nandyal district of Andhra Pradesh, India in adverse events monitoring associated with albendazole mass drug administration in school children. Though 2% of adverse events (AE) reported as non - serious in nature, found few gap areas in management of children those encountered with such adverse events. Therefore, necessary Standard Operating Procedures and risk management plan to be developed and healthcare workers trained accordingly to minimize the risk.

Author Biographies

  • Ciddhavaduta Deepa Latha, Professor & Head of Department, Department of Pharmacology, Mamata Academy of Medical Sciences, Bachupally, Hyderabad

    Ciddhavaduta Deepa Latha  Professor & Head of Department, Department of Pharmacology, Mamata Academy of Medical Sciences, Bachupally, Hyderabad

  • Vivekanandan Kalaiselvan, Principal Scientific Officer, Indian Pharmacopoeia Commission, Government of India (Ministry of Health & Family Welfare)

    Vivekanandan Kalaiselvan Principal Scientific Officer, Indian Pharmacopoeia Commission, Government of India (Ministry of Health & Family Welfare)

  • Nadithe Laxman Reddy, 3Assistant Professor, Department of Pharmacology, Mamtha Academy of Medical sciences, Bachupally, Hyderabad

     Nadithe Laxman Reddy Assistant Professor, Department of Pharmacology, Mamtha Academy of Medical sciences, Bachupally, Hyderabad

  • Raja Vikram Prasad, Professor, Department of Community Medicine, Mamata Academy of Medical Sciences, Hyderabad

     Raja Vikram Prasad Assistant Professor, Department of Community Medicine, Mamata Academy of Medical Sciences, Hyderabad

Downloads

Published

2021-02-24